Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 59,502 | 71,623 | 15,043 | 7,712 | 5,077 |
| Gross Profit | 59,502 | 71,623 | 15,043 | 7,712 | 5,077 |
| Operating Expenses | 137,376 | 117,882 | 74,629 | 40,915 | 34,842 |
| Operating Income | -77,874 | -46,259 | -59,586 | -33,203 | -29,765 |
| Interest Expense | 0 | 0 | 0 | 1,732 | 487 |
| Other Income | 7,573 | 2,647 | 667 | -429 | -48 |
| Pre-tax Income | -70,301 | -43,612 | -58,919 | -35,364 | -30,300 |
| Income Tax | 14,303 | -513 | -19 | 10 | 10 |
| Net Income Continuous | -84,604 | -43,099 | -58,900 | -35,374 | -30,310 |
| Net Income | $-84,604 | $-43,099 | $-58,900 | $-35,374 | $-30,310 |
| EPS Basic Total Ops | -2.03 | -1.16 | -1.63 | -4.90 | -35.25 |
| EPS Basic Continuous Ops | -2.03 | -1.16 | -1.63 | -4.12 | -30.65 |
| EPS Diluted Total Ops | -2.03 | -1.16 | -1.63 | -4.90 | -35.25 |
| EPS Diluted Continuous Ops | -2.03 | -1.16 | -1.63 | -4.12 | -30.65 |
| EPS Diluted Before Non-Recurring Items | -2.03 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-77,691 | $-44,226 | $-56,191 | $-30,731 | $-28,942 |